Bacil Pharma Ltd.
| BSE: 524516 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE711D01018 |
| BSE 00:00 | 30 Nov | 7.78 |
0.37 (4.99%) |
OPEN
7.41 |
HIGH
7.78 |
LOW
7.41 |
| NSE 05:30 | 01 Jan | Bacil Pharma Ltd Not listed in NSE |
| OPEN | 7.41 |
| PREVIOUS CLOSE | 7.41 |
| VOLUME | 110 |
| 52-Week high | 9.55 |
| 52-Week low | 3.67 |
| P/E | |
| Mkt Cap.(Rs cr) | 5 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
About Bacil Pharma Ltd.
Incorporated as a private limited company in Maharashtra in May '87 Bacil Pharma (BPL) was converted into a public limited company in Oct.'90. BPL came out with a public issue of Rs 7 cr in Mar.'94 to set up a plant at Vapi to manufacture bulk drugs like atenalol norfloxacin pefloxacin and ciprofloxacin. The comapany entered into a marketing arrangement with a distributor Kam Han Industries Hong K...> More
Bacil Pharma Ltd - Key Fundamentals
| Parameter | Values | ||
| Market Cap | ( cr) |
5 | |
| EPS - TTM | () |
[*S] | - |
| P/E Ratio | (X) | [*S] | - |
| Face Value | () |
10 | |
| Latest Dividend | (%) | - | |
| Latest Dividend Date | - | ||
| Dividend Yield | (%) | 0.00 | |
| Book Value / Share | () |
[*S] | 1.04 |
| P/B Ratio | () |
[*S] | 7.48 |
Announcement
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
-
SUBMISSION OF UN-AUDITED QUARTERLY FINANCIALS FOR THE QUARTER ENDED 30.09.2022
-
Board Meeting Outcome for SUBMISSION OF UN-AUDITED QUARTERLY FINANCIALS
-
Board Meeting Intimation for Consideration And Approval Of The Un-Audited Financial Results Along W
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Bacil Pharma Ltd - Financial Results
Particulars ( cr) |
Sep 2022 | Sep 2021 | % Chg |
| Net Sales | - | ||
| Other Income | 0.04 | 0.02 | 100 |
| Total Income | 0.04 | 0.02 | 100 |
| Total Expenses | 0.04 | 0.09 | -55.56 |
| Operating Profit | -0.08 | - | |
| Net Profit | -0.08 | - | |
| Equity Capital | 5.89 | 5.89 | - |
Bacil Pharma Ltd - Peer Group
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Chemo Pharma Lab | 41.55 | 0.24 | 6.23 |
| Beryl Drugs | 11.00 | 3.68 | 5.58 |
| Unjha Formul. | 10.50 | 5.00 | 4.70 |
| Bacil Pharma | 7.78 | 4.99 | 4.58 |
| Hind.Bio Science | 4.00 | 0.00 | 4.10 |
| Adline Chem Lab | 6.85 | -4.99 | 4.01 |
Bacil Pharma Ltd - SHAREHOLDING PATTERN
|
|
|
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
OtherBacil Pharma Ltd - RETURNS
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | NA | NA | 2.58% | 2.69% |
| 1 Month | -4.89% | NA | 5.24% | 5.46% |
| 3 Month | 69.50% | NA | 5.98% | 5.63% |
| 6 Month | 45.15% | NA | 12.83% | 12.59% |
| 1 Year | 80.51% | NA | 10.58% | 10.45% |
| 3 Year | NA | NA | 54.68% | 55.59% |
Bacil Pharma Ltd - STOCK STRENGTH
| Today's Low/High | 7.41 |
|
7.78 |
| Week Low/High | 7.06 |
|
7.78 |
| Month Low/High | 6.18 |
|
9.00 |
| YEAR Low/High | 3.67 |
|
10.00 |
| All TIME Low/High | 0.80 |
|
25.00 |
Quick Links for Bacil Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
